Penserra Capital Management LLC Bristol Myers Squibb CO Transaction History
Penserra Capital Management LLC
- $7.65 Billion
- Q3 2025
A detailed history of Penserra Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penserra Capital Management LLC holds 165 shares of BMY stock, worth $7,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165
Previous 165
-0.0%
Holding current value
$7,723
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,682Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...